Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gieseler

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Leukemia|July 17, 1998
Cellular resistance mechanisms with impact on the therapy of multiple myelomaF Gieseler, V Nüssler
Leukemia|January 22, 1998
Cellular resistance mechanisms with impact on the therapy of multiple myelomaF Gieseler, V Nüssler
Toxicology Letters|April 1, 1993
Topoisomerase II function detected as protein-DNA complexes in two sublines of HL-60 cellsP Meyer, F Boege, F Gieseler
Environmental Health Perspectives|August 1, 1990
Alteration of topoisomerase II action is a possible molecular mechanism of HL-60 cell differentiationF Gieseler, F Boege, M Clark
Der Internist|February 1, 2015
[Obesity and cancer]H Ungefroren, F Gieseler, H Lehnert
European Journal of Clinical Pharmacology|August 24, 1999
Influence of serum protein binding on the uptake and retention of idarubicin by sensitive and multidrug resistant human leukemic cellsM Kessel, F Gieseler, B G Woodcock
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|February 1, 1992
The measurement of nuclear topoisomerase II inhibition in vitro: a possible tool for detecting resistance on a subcellular level in haematopoietic malignanciesF Boege, F Gieseler, H Biersack, et al.
Blut|March 1, 1989
Granulocytic differentiation of HL-60 cells is not regulated by DNA de novo methylationF Gieseler, P Meyer, D Schiffmann, et al.
Leukemia & Lymphoma|March 1, 1993
Different functional states of topoisomerase II can be discriminated by orthovanadate sensitivity in multi-drug resistant human leukemic cellsF Boege, F Gieseler, H Biersack, et al.
Toxicology Letters|April 1, 1993
Correlation between the DNA-binding affinity of topoisomerase inhibiting drugs and their capacity to induce hematopoetic cell differentiationF Gieseler, F Boege, M Clark, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Leukemia|July 17, 1998
Cellular resistance mechanisms with impact on the therapy of multiple myelomaF Gieseler, V Nüssler
Leukemia|January 22, 1998
Cellular resistance mechanisms with impact on the therapy of multiple myelomaF Gieseler, V Nüssler
Toxicology Letters|April 1, 1993
Topoisomerase II function detected as protein-DNA complexes in two sublines of HL-60 cellsP Meyer, F Boege, F Gieseler
Environmental Health Perspectives|August 1, 1990
Alteration of topoisomerase II action is a possible molecular mechanism of HL-60 cell differentiationF Gieseler, F Boege, M Clark
Der Internist|February 1, 2015
[Obesity and cancer]H Ungefroren, F Gieseler, H Lehnert
European Journal of Clinical Pharmacology|August 24, 1999
Influence of serum protein binding on the uptake and retention of idarubicin by sensitive and multidrug resistant human leukemic cellsM Kessel, F Gieseler, B G Woodcock
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|February 1, 1992
The measurement of nuclear topoisomerase II inhibition in vitro: a possible tool for detecting resistance on a subcellular level in haematopoietic malignanciesF Boege, F Gieseler, H Biersack, et al.
Blut|March 1, 1989
Granulocytic differentiation of HL-60 cells is not regulated by DNA de novo methylationF Gieseler, P Meyer, D Schiffmann, et al.
Leukemia & Lymphoma|March 1, 1993
Different functional states of topoisomerase II can be discriminated by orthovanadate sensitivity in multi-drug resistant human leukemic cellsF Boege, F Gieseler, H Biersack, et al.
Toxicology Letters|April 1, 1993
Correlation between the DNA-binding affinity of topoisomerase inhibiting drugs and their capacity to induce hematopoetic cell differentiationF Gieseler, F Boege, M Clark, et al.
Pageof 5